These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 32901857

  • 1. Downregulation of exosomal miR‑1273a increases cisplatin resistance of non‑small cell lung cancer by upregulating the expression of syndecan binding protein.
    Zhao X, Li M, Dai X, Yang Y, Peng Y, Xu C, Dai N, Wang D.
    Oncol Rep; 2020 Nov; 44(5):2165-2173. PubMed ID: 32901857
    [Abstract] [Full Text] [Related]

  • 2. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
    Song Z, Jia G, Ma P, Cang S.
    Life Sci; 2021 Jul 01; 276():119399. PubMed ID: 33781830
    [Abstract] [Full Text] [Related]

  • 3. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL, Sheng BB, Liu J, Wenyu W, Shu YQ.
    Eur Rev Med Pharmacol Sci; 2017 Jun 01; 21(11):2650-2658. PubMed ID: 28678319
    [Abstract] [Full Text] [Related]

  • 4. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N, Song L, Sun X.
    Mol Cell Biochem; 2021 Jun 01; 476(6):2253-2267. PubMed ID: 33570734
    [Abstract] [Full Text] [Related]

  • 5. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.
    Ma Y, Yuwen D, Chen J, Zheng B, Gao J, Fan M, Xue W, Wang Y, Li W, Shu Y, Xu Q, Shen Y.
    Int J Nanomedicine; 2019 Jun 01; 14():8121-8132. PubMed ID: 31632022
    [Abstract] [Full Text] [Related]

  • 6. CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging.
    Zhang T, Zhang P, Li HX.
    Int J Nanomedicine; 2021 Jun 01; 16():561-577. PubMed ID: 33542625
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
    Wang D, Zhao C, Xu F, Zhang A, Jin M, Zhang K, Liu L, Hua Q, Zhao J, Liu J, Yang H, Huang G.
    Theranostics; 2021 Jun 01; 11(6):2860-2875. PubMed ID: 33456577
    [Abstract] [Full Text] [Related]

  • 8. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H, Huang H, Wang L, Liu Y, Wang M, Zhao S, Lu G, Kang X.
    Aging (Albany NY); 2021 May 17; 13(10):14456-14468. PubMed ID: 33999859
    [Abstract] [Full Text] [Related]

  • 9. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
    Yuwen D, Ma Y, Wang D, Gao J, Li X, Xue W, Fan M, Xu Q, Shen Y, Shu Y.
    Cancer Epidemiol Biomarkers Prev; 2019 Jan 17; 28(1):163-173. PubMed ID: 30228154
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J.
    Int J Nanomedicine; 2017 Jan 17; 12():3721-3733. PubMed ID: 28553110
    [Abstract] [Full Text] [Related]

  • 11. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.
    Huang G, Lou T, Pan J, Ye Z, Yin Z, Li L, Cheng W, Cao Z.
    Aging (Albany NY); 2019 Apr 12; 11(7):2138-2150. PubMed ID: 30981205
    [Abstract] [Full Text] [Related]

  • 12. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
    Shen Q, Xu Z, Xu S.
    Int J Oncol; 2020 Oct 12; 57(4):967-979. PubMed ID: 32945379
    [Abstract] [Full Text] [Related]

  • 13. Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients.
    Janpipatkul K, Trachu N, Watcharenwong P, Panvongsa W, Worakitchanon W, Metheetrairut C, Oranratnachai S, Reungwetwattana T, Chairoungdua A.
    Cancer Biomark; 2021 Oct 12; 31(3):281-294. PubMed ID: 33896827
    [Abstract] [Full Text] [Related]

  • 14. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS, Zheng YL, Zhao J, Chun X.
    Biomed Pharmacother; 2018 Feb 12; 98():538-544. PubMed ID: 29287202
    [Abstract] [Full Text] [Related]

  • 15. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer.
    Peng XX, Yu R, Wu X, Wu SY, Pi C, Chen ZH, Zhang XC, Gao CY, Shao YW, Liu L, Wu YL, Zhou Q.
    J Immunother Cancer; 2020 Jan 12; 8(1):. PubMed ID: 31959728
    [Abstract] [Full Text] [Related]

  • 16. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH, He SY.
    Eur Rev Med Pharmacol Sci; 2020 Mar 12; 24(6):3130-3142. PubMed ID: 32271431
    [Abstract] [Full Text] [Related]

  • 17. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
    Yang Y, Zhang P, Zhao Y, Yang J, Jiang G, Fan J.
    Cancer Biol Ther; 2016 May 03; 17(5):515-25. PubMed ID: 26492332
    [Abstract] [Full Text] [Related]

  • 18. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G.
    Cancer Res; 2010 Mar 01; 70(5):1793-803. PubMed ID: 20145152
    [Abstract] [Full Text] [Related]

  • 19. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T, Zhou L, Wang T, Xu J, Wang J, Chen W, Zhou X, Huang Z, Zhu W, Shu Y, Liu P.
    Int J Mol Med; 2013 Sep 01; 32(3):593-8. PubMed ID: 23856992
    [Abstract] [Full Text] [Related]

  • 20. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q, Xing S, Peng A, Yu Z.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31894841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.